188 related articles for article (PubMed ID: 29978518)
1. Combination of 5-aminolevulinic acid and iron prevents skin fibrosis in murine sclerodermatous graft-versus-host disease.
Liu C; Yang X; Zhu P; Fujino M; Ito H; Takahashi K; Nakajima M; Tanaka T; Wang J; Zhuang J; Zou H; Li XK
Exp Dermatol; 2018 Oct; 27(10):1104-1111. PubMed ID: 29978518
[TBL] [Abstract][Full Text] [Related]
2. Latency-associated peptide prevents skin fibrosis in murine sclerodermatous graft-versus-host disease, a model for human scleroderma.
Zhang Y; McCormick LL; Gilliam AC
J Invest Dermatol; 2003 Oct; 121(4):713-9. PubMed ID: 14632186
[TBL] [Abstract][Full Text] [Related]
3. 5-aminolevulinic acid combined with sodium ferrous citrate ameliorated lupus nephritis in a mouse chronic graft-versus-host disease model.
Liu C; Wang Z; Hu X; Ito H; Takahashi K; Nakajima M; Tanaka T; Zhu P; Li XK
Int Immunopharmacol; 2021 Jul; 96():107626. PubMed ID: 33862551
[TBL] [Abstract][Full Text] [Related]
4. Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation.
Zhang Y; McCormick LL; Desai SR; Wu C; Gilliam AC
J Immunol; 2002 Mar; 168(6):3088-98. PubMed ID: 11884483
[TBL] [Abstract][Full Text] [Related]
5. 5-Aminolevulinic acid combined with sodium ferrous citrate (5-ALA/SFC) ameliorated liver injury in a murine acute graft-versus-host disease model by reducing inflammation responses through PGC1-α activation.
Wang Z; Ma K; Liu C; Hu X; Que W; Ito H; Takahashi K; Nakajima M; Tanaka T; Ren K; Guo WZ; Yi SQ; Li XK
Drug Discov Ther; 2021 Jan; 14(6):304-312. PubMed ID: 33390570
[TBL] [Abstract][Full Text] [Related]
6. Anti-TGF-beta treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma.
McCormick LL; Zhang Y; Tootell E; Gilliam AC
J Immunol; 1999 Nov; 163(10):5693-9. PubMed ID: 10553100
[TBL] [Abstract][Full Text] [Related]
7. 5-aminolevulinic acid combined with sodium ferrous citrate ameliorates H2O2-induced cardiomyocyte hypertrophy via activation of the MAPK/Nrf2/HO-1 pathway.
Zhao M; Guo H; Chen J; Fujino M; Ito H; Takahashi K; Abe F; Nakajima M; Tanaka T; Wang J; Huang H; Zheng S; Hei M; Li J; Huang S; Li J; Ma X; Chen Y; Zhao L; Zhuang J; Zhu P; Li XK
Am J Physiol Cell Physiol; 2015 Apr; 308(8):C665-72. PubMed ID: 25652453
[TBL] [Abstract][Full Text] [Related]
8. 5-Aminolevulinic acid combined with ferrous iron enhances the expression of heme oxygenase-1.
Nishio Y; Fujino M; Zhao M; Ishii T; Ishizuka M; Ito H; Takahashi K; Abe F; Nakajima M; Tanaka T; Taketani S; Nagahara Y; Li XK
Int Immunopharmacol; 2014 Apr; 19(2):300-7. PubMed ID: 24530569
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of phosphodiesterase 4 (PDE4) reduces dermal fibrosis by interfering with the release of interleukin-6 from M2 macrophages.
Maier C; Ramming A; Bergmann C; Weinkam R; Kittan N; Schett G; Distler JHW; Beyer C
Ann Rheum Dis; 2017 Jun; 76(6):1133-1141. PubMed ID: 28209630
[TBL] [Abstract][Full Text] [Related]
10. Blockade of p38 Mitogen-Activated Protein Kinase Inhibits Murine Sclerodermatous Chronic Graft-versus-Host Disease.
Matsushita T; Date M; Kano M; Mizumaki K; Tennichi M; Kobayashi T; Hamaguchi Y; Hasegawa M; Fujimoto M; Takehara K
Am J Pathol; 2017 Apr; 187(4):841-850. PubMed ID: 28189565
[TBL] [Abstract][Full Text] [Related]
11. Oral administration of 5-aminolevulinic acid induces heme oxygenase-1 expression in peripheral blood mononuclear cells of healthy human subjects in combination with ferrous iron.
Ito H; Nishio Y; Hara T; Sugihara H; Tanaka T; Li XK
Eur J Pharmacol; 2018 Aug; 833():25-33. PubMed ID: 29753693
[TBL] [Abstract][Full Text] [Related]
12. 5-Aminolevulinic acid with ferrous iron induces permanent cardiac allograft acceptance in mice via induction of regulatory cells.
Hou J; Zhang Q; Fujino M; Cai S; Ito H; Takahashi K; Abe F; Nakajima M; Tanaka T; Xu J; Zou H; Ding Q; Li XK
J Heart Lung Transplant; 2015 Feb; 34(2):254-63. PubMed ID: 25455753
[TBL] [Abstract][Full Text] [Related]
13. A modified graft-versus-host-induced model for systemic sclerosis, with pulmonary fibrosis in Rag2-deficient mice.
Yang X; Liu C; Fujino M; Yang J; Li XK; Zou H
FEBS Open Bio; 2017 Sep; 7(9):1316-1327. PubMed ID: 28904861
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of murine sclerodermatous models by the selective S1P
Kano M; Kobayashi T; Date M; Tennichi M; Hamaguchi Y; Strasser DS; Takehara K; Matsushita T
Sci Rep; 2019 Jan; 9(1):658. PubMed ID: 30679645
[TBL] [Abstract][Full Text] [Related]
15. Anti-CX3CL1 (fractalkine) monoclonal antibody attenuates lung and skin fibrosis in sclerodermatous graft-versus-host disease mouse model.
Hasegawa T; Utsunomiya A; Chino T; Kasamatsu H; Shimizu T; Matsushita T; Obara T; Ishii N; Ogasawara H; Ikeda W; Imai T; Oyama N; Hasegawa M
Arthritis Res Ther; 2024 May; 26(1):94. PubMed ID: 38702742
[TBL] [Abstract][Full Text] [Related]
16. 5-Aminolevulinic acid/sodium ferrous citrate enhanced the antitumor effects of programmed cell death-ligand 1 blockade by regulation of exhausted T cell metabolism in a melanoma model.
Hu X; Que W; Hirano H; Wang Z; Nozawa N; Ishii T; Ishizuka M; Ito H; Takahashi K; Nakajima M; Tanaka T; Zhu P; Guo WZ; Li XK
Cancer Sci; 2021 Jul; 112(7):2652-2663. PubMed ID: 33934440
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous gene expression by DNA microarray in murine sclerodermatous graft-versus-host disease, a model for human scleroderma.
Zhou L; Askew D; Wu C; Gilliam AC
J Invest Dermatol; 2007 Feb; 127(2):281-92. PubMed ID: 16917493
[TBL] [Abstract][Full Text] [Related]
18. 5-Aminolevulinic acid with sodium ferrous citrate induces autophagy and protects cardiomyocytes from hypoxia-induced cellular injury through MAPK-Nrf-2-HO-1 signaling cascade.
Zhao M; Zhu P; Fujino M; Nishio Y; Chen J; Ito H; Takahashi K; Nakajima M; Tanaka T; Zhao L; Zhuang J; Li XK
Biochem Biophys Res Commun; 2016 Oct; 479(4):663-669. PubMed ID: 27693692
[TBL] [Abstract][Full Text] [Related]
19. FTY720 ameliorates murine sclerodermatous chronic graft-versus-host disease by promoting expansion of splenic regulatory cells and inhibiting immune cell infiltration into skin.
Huu DL; Matsushita T; Jin G; Hamaguchi Y; Hasegawa M; Takehara K; Fujimoto M
Arthritis Rheum; 2013 Jun; 65(6):1624-35. PubMed ID: 23508350
[TBL] [Abstract][Full Text] [Related]
20. Recombinant Adenosine Deaminase Ameliorates Inflammation, Vascular Disease, and Fibrosis in Preclinical Models of Systemic Sclerosis.
Zhang Y; Zhu H; Layritz F; Luo H; Wohlfahrt T; Chen CW; Soare A; Bergmann C; Ramming A; Groeber F; Reuter C; Fornasini G; Soukhareva N; Schreiber B; Ramamurthy S; Amann K; Schett G; Distler JHW
Arthritis Rheumatol; 2020 Aug; 72(8):1385-1395. PubMed ID: 32182396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
